On Feb. 1, Novartis Pharmaceuticals Canada Inc. announced that the Nova Scotia government is funding Pluvicto injections for ...

2. Ovarian Cancer: Research indicates that a woman's chance of developing ovarian cancer may be influenced by hormonal ...

Prostate cancer is one of the most prevalent cancers among men and poses a significant health concern, with its incidence on ...

A new drug, NXP800, shows promise in treating hormone therapy-resistant prostate cancer by targeting the Heat Shock Factor 1 (HSF1) pathway, which supports cancer cell growth.

Hormone therapy is used to slow the progression of advanced prostate cancer, but cancers often develop resistance and continue to grow Research reveals that patients with higher levels of heat shock ...

In a live event, Vinay Minocha, MD, discusses the addition of darolutamide to androgen deprivation therapy for in patients ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research published in ...

Prostate Cancer: Dihydrotestosterone (DHT), a stronger ... endometriosis, and long-term hormone therapy use. Oestrogen and progesterone, two female sex hormones, are dosed in birth control pills ...

In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.

Today, on World Cancer Day, we come together to raise awareness, promote early detection and encourage prevention.

For an entire week after my dream, I kept the blood pressure cuff handy at my bedside in case I was awakened again with a ...

Professor Adrian Crellin, 70, noticed blood in his urine and promptly sought medical attention from his GP, leading to a ...